Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study ; volume:23 ; number:1 ; day:12 ; month:8 ; year:2023 ; pages:1-8 ; date:12.2023
BMC surgery ; 23, Heft 1 (12.8.2023), 1-8, 12.2023
- Creator
-
Qiu, Wenqiang
Zhou, Ge
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12893-023-02143-y
- URN
-
urn:nbn:de:101:1-2023110309252271836937
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qiu, Wenqiang
- Zhou, Ge
- SpringerLink (Online service)
Other Objects (12)
Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study
Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study
Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism
Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study
Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study
Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism
Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study
Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism
The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study